Previous 10 | Next 10 |
CAMBRIDGE, MA / ACCESSWIRE / September 14, 2023 / Allarity Therapeutics (NASDAQ:ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer therapies coupled with companion diagnostics. The company's unique approach involves utilizing its p...
2023-09-01 08:42:36 ET Aditxt ( ADTX ) -49% announces $10.0 Million private placement priced at-the-market under Nasdaq rules. iCoreConnect ( ICCT ) -22% . Flora Growth Corp. ( FLGC ) -17% . Biodexa Pharmaceuticals ( BDRX ) -15% . Tingo ...
2023-08-31 10:00:40 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) Tech Ruled The First Half Of 2023, The Industry You Need To Watch In The Second Half XLV Vs. VHT: A Head-To-Head Healthcare ETF C...
2023-08-31 08:26:12 ET Prime Number Acquisition ( NCNC ) +39% . Allarity Therapeutics ( ALLR ) +35% . iCoreConnect ( ICCT ) +34% . NLS Pharmaceutics ( NLSP ) +19% . Tingo Group ( TIO ) +14% Reports Second Quarter 2023 Financi...
- T he DRP ® -Dovitinib companion diagnostic demonstrated an ability to identify advanced renal cell carcinoma patients that have improved clinical benefit from dovitinib treatment , as compared to unselected patients BOSTON (August...
2023-08-01 08:38:44 ET TG Therapeutics ( TGTX ) -40% after Q2 earning release . ZoomInfo Technologies ( ZI ) -20% after Q2 earning release . Vision Marine Technologies ( VMAR ) -18% on direct registered offering of 0.49M shares at $4.05 . Ze...
2023-07-31 08:37:42 ET China Natural Resources ( NASDAQ: CHNR ) +49% . Allarity Therapeutics ( ALLR ) +31% . Barnes & Noble Education ( BNED ) +17% . Spero Therapeutics ( SPRO ) +13% Announces Special Protocol Assessment Agreement with FDA...
BOSTON and SYDNEY (July 31, 2023) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® companion diagnostics for personalized cancer care, and Detsa...
New appointments bring therapeutic development expertise and proven leadership to support continu ed progress of Allarity’s mult i ple oncology clinical programs BOSTON (July 24, 2023) — Allarity Therapeutics, Inc. (Allarit...
2023-07-10 10:03:22 ET Gainers: NanoString Technologies ( NSTG ) +23% . NeuroOne Medical Technologies Corporation ( NMTC ) +21% . Novavax ( NVAX ) +18% . Sientra ( SIEN ) +15% . Losers: Outset Medical ( OM ) -12% . PainRe...
News, Short Squeeze, Breakout and More Instantly...
Allarity Therapeutics Inc. Company Name:
ALLR Stock Symbol:
NASDAQ Market:
Allarity Therapeutics Inc. Website:
Boston (June 27, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that it received notice from the NASDAQ S...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 6.8% to $126.09 on volume of 414,790,976 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 18.7% to $0.265 on volume of 162,165,405 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 12.6%...
Multiple patients have now exceeded 30 weeks on treatment Boston (June 25, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer...